GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Xiamen Kingdomway Group Co (SZSE:002626) » Definitions » Research & Development

Xiamen Kingdomway Group Co (SZSE:002626) Research & Development : ¥60 Mil (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Xiamen Kingdomway Group Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Xiamen Kingdomway Group Co's Research & Development for the three months ended in Mar. 2024 was ¥16 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥60 Mil.


Xiamen Kingdomway Group Co Research & Development Historical Data

The historical data trend for Xiamen Kingdomway Group Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiamen Kingdomway Group Co Research & Development Chart

Xiamen Kingdomway Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.81 73.71 82.95 71.86 58.20

Xiamen Kingdomway Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.54 14.92 21.45 7.29 16.08

Xiamen Kingdomway Group Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xiamen Kingdomway Group Co  (SZSE:002626) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Xiamen Kingdomway Group Co Research & Development Related Terms

Thank you for viewing the detailed overview of Xiamen Kingdomway Group Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiamen Kingdomway Group Co (SZSE:002626) Business Description

Traded in Other Exchanges
N/A
Address
Xinyang Industrial Zone, Fujian, Haishu, Xiamen, CHN, 361028
Xiamen Kingdomway Group Co is a China-based company mainly engaged in the development and innovation of nutrition enhancer and bio-medical products. The company's main products are Coenzyme Q10, microalgae DHA, plant ARA, vitamin A, and vitamin D3.
Executives
Zhang Shui Lu Executives
Huang Xing Luan Independent director
Zhan Guang Huang Executives
Yang Chao Yong Independent director
Xu Lv Zhong Supervisors
Zhan Rui Director
Hong Yan Directors, executives
Ma Guo Qing Directors, executives
Jiang Bin Directors, executives
Chen Rui Chen Directors, executives
Lu Ying Hua Director

Xiamen Kingdomway Group Co (SZSE:002626) Headlines

No Headlines